CB Oncology Partners (Tables)

9 Months Ended

Sep. 30, 2022

CB Oncology Partners LLC [Member]

Schedule of Equity Method Investments [Line Items]

Equity Method Investment Summarized Financial Information

The following table presents the summarized financial information of CBOP:

CBOP Condensed Income Statement Information

	Nine Months Ended
	September 30,
	2022			2021
Patient revenue	$	1,507,000		$	1,591,000
Net (loss) income	$	(387,000	)	$	69,000
USNC’s equity in (loss) income of CBOP	$	(111,000	)	$	20,000

	Three Months Ended
	September 30,
	2022			2021
Patient revenue	$	482,000		$	550,000
Net loss	$	(158,000	)	$	(23,000	)
USNC’s equity in loss of CBOP	$	(45,000	)	$	(7,000	)

CBOP Condensed Balance Sheet Information

	September 30,			December 31,
	2022			2021
Current assets	$	444,000		$	400,000
Noncurrent assets		3,209,000			3,667,000
Total assets	$	3,653,000		$	4,067,000
Current liabilities	$	3,598,000		$	3,472,000
Noncurrent liabilities		2,968,000			3,121,000
Deficit		(2,913,000	)		(2,526,000	)
Total liabilities and deficit	$	3,653,000		$	4,067,000